COVAX Facility announces vaccines release for first half of 2021

The COVAX Initiative expects to release first doses of the Pfizer/BioNTec vaccine and the AstraZeneca/Oxford vaccine during the first half of 2021 to COVAX Facility participants. Twelve South Pacific countries are included in its first “interim distribution forecast” that targets at least 3% of their populations.